Stock Scorecard
Stock Summary for Global Medical REIT Inc (GMRE) - $7.75 as of 5/5/2025 8:14:37 PM EST
Total Score
7 out of 30
Safety Score
35 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for GMRE
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for GMRE
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for GMRE
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for GMRE
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for GMRE (35 out of 100)
Stock Price Rating (Max of 10) | 4 |
Historical Stock Price Rating (Max of 10) | 5 |
Stock Price Trend (Max of 10) | 2 |
Book Value (Max of 10) | 4 |
Book Value to Price (Max of 10) | 1 |
Analyst Buy Ratings (Max of 5) | 4 |
Analyst Strong Buy Ratings (Max of 5) | 3 |
Dividend Yield Percentage (Max of 10) | 2 |
Operating Margin (Max of 10) | 4 |
Trading Volume (Max of 10) | 5 |
Price to Earnings (Max of 10) | 1 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for GMRE
Financial Details for GMRE
Company Overview |
|
---|---|
Ticker | GMRE |
Company Name | Global Medical REIT Inc |
Country | USA |
Description | N/A |
Sector Name | TRADE & SERVICES |
Industry Name | SERVICES-PERSONAL SERVICES |
Most Recent Quarter | 12/31/2024 |
Next Earnings Date | 5/5/2025 |
Stock Price History |
|
Last Day Price | 7.75 |
Price 4 Years Ago | 13.34 |
Last Day Price Updated | 5/5/2025 8:14:37 PM EST |
Last Day Volume | 269,786 |
Average Daily Volume | 562,497 |
52-Week High | 9.73 |
52-Week Low | 6.75 |
Last Price to 52 Week Low | 14.81% |
Valuation Measures |
|
Trailing PE | 770.00 |
Industry PE | 114.74 |
Sector PE | 46.20 |
5-Year Average PE | 0.16 |
Free Cash Flow Ratio | 77.50 |
Industry Free Cash Flow Ratio | 45.67 |
Sector Free Cash Flow Ratio | 56.85 |
Current Ratio Most Recent Quarter | 0.03 |
Total Cash Per Share | 0.10 |
Book Value Per Share Most Recent Quarter | 6.87 |
Price to Book Ratio | 1.14 |
Industry Price to Book Ratio | 14.67 |
Sector Price to Book Ratio | 8.90 |
Price to Sales Ratio Twelve Trailing Months | 7.59 |
Industry Price to Sales Ratio Twelve Trailing Months | 2.30 |
Sector Price to Sales Ratio Twelve Trailing Months | 2.02 |
Analyst Buy Ratings | 4 |
Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
Total Shares Outstanding | 66,879,000 |
Market Capitalization | 518,312,250 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | 3/21/2025 |
Previous Dividend Amount | 0.2100 |
Current Dividend Amount | 0.2100 |
Total Years Dividend Increasing | 0 |
Trailing Annual Dividend Rate | 0.84 |
Trailing Annual Dividend Yield | 10.91% |
Forward Annual Dividend Rate | 0.84 |
Forward Annual Dividend Yield | 10.91% |
5-Year Dividend Payments Count | 20 |
3-Year Average Dividend Yield | 11.15% |
5-Year Average Dividend Yield | 9.19% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.60% |
All-Time Dividend Growth Rate Percentage | 9.43% |
Dividend Payout Ratio | 8,400.00% |
Income Statement |
|
Quarterly Earnings Growth YOY | -43.10% |
Annual Earnings Growth | -67.82% |
Reported EPS 12 Trailing Months | 0.01 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | -0.05 |
Net Income Twelve Trailing Months | 6,633,000 |
Net Income Past Year | 6,633,000 |
Net Income Prior Year | 20,612,000 |
Quarterly Revenue Growth YOY | 6.60% |
5-Year Revenue Growth | 14.37% |
Operating Margin Twelve Trailing Months | 18.30% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 6,815,000 |
Total Cash Past Year | 6,815,000 |
Total Cash Prior Year | 1,278,000 |
Net Cash Position Most Recent Quarter | -7,584,000 |
Net Cash Position Past Year | -7,584,000 |
Long Term Debt Past Year | 14,399,000 |
Long Term Debt Prior Year | 25,899,000 |
Total Debt Most Recent Quarter | 14,399,000 |
Equity to Debt Ratio Past Year | 0.97 |
Equity to Debt Ratio Most Recent Quarter | 0.97 |
Total Stockholder Equity Past Year | 534,126,000 |
Total Stockholder Equity Prior Year | 583,584,000 |
Total Stockholder Equity Most Recent Quarter | 534,126,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | 5,766,000 |
Free Cash Flow Per Share Twelve Trailing Months | 0.09 |
Free Cash Flow Past Year | -25,073,000 |
Free Cash Flow Prior Year | 58,394,000 |
Options |
|
Put/Call Ratio | 1.50 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.10 |
MACD Signal | -0.17 |
20-Day Bollinger Lower Band | 6.91 |
20-Day Bollinger Middle Band | 7.88 |
20-Day Bollinger Upper Band | 8.85 |
Beta | 1.17 |
RSI | 48.94 |
50-Day SMA | 8.31 |
150-Day SMA | 8.16 |
200-Day SMA | 9.03 |
System |
|
Modified | 5/3/2025 12:55:26 AM EST |